Media

Here are a collection of major media mentions and some of the bits and pieces that I have written, contributed to, or in which my research has been quoted.

On competing interests in biomedical research

In The Pharmaceutical Journal, a piece by Kirsty Oswald, which includes my thoughts on an article in the BMJ that separated the effects of funding from authors’ financial conflicts of interests. [January 2017]

On Radio National’s Health Report with Joel Werner, talking about a proposal for a registry covering the competing interests of all researchers. [June 2016]

In the Higher Education section of The Australian, John Ross covers my proposal for a global registry for competing interests in research. [May 2016]

I wrote more about the proposal for a global registry for This Week at Macquarie University. [May 2016]

In MedScape, on the results of the new Roche funded review of Tamiflu, published after we identified an association between conclusions and conflicts of interest in systematic reviews. [February 2015]

Newsweek included information about our research in the cover story on pharmaceutical companies hiding data about the drugs they market. [November 2014]

Michael McCarthy from the BMJ covered our research on financial conflicts of interest in systematic reviews of neuraminidase inhibitors, including asking extra questions. [October 2014]

Melissa Davey from the Guardian covered our research on financial conflicts of interest in systematic reviews of neuraminidase inhibitors, interviewing Florence Bourgeois, Ray Moynihan, and me. [October 2014]

Nicole Ostrow from Bloomberg covered our research on financial conflicts of interest in systematic reviews of neuraminidase inhibitors as well as the implications, interviewing Florence Bourgeois, Christine Laine, Austine Graff, and me. [October 2014]

Kimberly Leonard from US News covered our story about financial conflicts of interest in neuraminidase inhibitors and other recent news, interviewing Florence Bourgeois and me, as well as including a statement from Genentech. [October 2014]

The Australian Doctor magazine also covered our research on financial conflicts of interest in systematic reviews of neuraminidase inhibitors. [October 2014]

Our research on neuraminidase inhibitors and financial conflicts of interest was covered in Wall Street Journal Pharmalot. [October 2014]

Fierce Pharma covered our research on the influence of financial conflicts of interest on the conclusions of systematic reviews about neuraminidase inhibitors. [October 2014]

On public health surveillance and vaccine misinformation online

In Croakey, Julie Leask and I wrote about our study on the association between the exposure to misinformation and the echo chambers of vaccine misinformation on Twitter. [June 2015]

On open access and open data

Melissa Davey from The Guardian, with contributions from many others, on the future of academic publishing. [August 2015]

Melissa Davey from The Guardian, with contributions from Chris Del Mar, Martin Tatersall, and me, on open access, Elsevier and integrity in editorial processes in relation to the Medical Journal of Australia. [May 2015]

With Upulie Divisekera, an article about current issues in open access, written for Crikey[February 2013]

The Sydney Morning Herald printed a summary of our research on open source clinical trial data on page 15 on the Thursday edition of the paper. [May 2012]

On why clinical research should be freely exchanged in the Sydney Morning Herald’s National Timeswith Enrico Coiera. [May 2012]

In the Higher Education section of The Australianjournalists described the research on open source clinical trial data. [May 2012]

 

On industry bias in biomedical research

As a guest columnist in the WA Medical Forum (page 31), discussing the potential problems associated with complementary medicine companies funding open-ended research in universities. [July 2015]

On Mark Colvin’s ABC radio program (PM), interviewed by Bill Birtles on the effects of industry funding on the potential to introduce detrimental biases into research. [May 2015]

In The Conversation, I wrote an article with Florence Bourgeois on the effects of financial conflicts of interest on systematic reviews, with specific examples from our research on neuraminidase inhibitors. [October 2014]

In The Conversation, as an expert in an article about the Swisse research collaboration with La Trobe University and the Complementary Medicine Evidence Centre. [February 2014]

On industry bias in evidence synthesis for The Conversation, with Ian Kerridge and Wendy Lipworth. [December 2012]

For The Conversation about the influence of big pharmaceutical companies on publications about the drugs they produce. [April 2012]

Early-career research advice

For the Guardian’s Higher Education Network on “the power of no” [April 2013]